BDBM261164 1-(4-(3-(1-(4-amino-3-methyl-1H- pyrazolo[3,4-d]pyrimidin-1- yl)ethyl)-5-chloro-2-methoxy-6- methylphenyl)pyridin-2- yl)azetidin-3-ol3::US9707233, 187
SMILES: COc1c(cc(Cl)c(C)c1-c1cncc(c1)N1CC(O)C1)C(C)Nc1ncnc(N)c1C(C)=N
InChI Key: InChIKey=AHEBMJSPCZIQGP-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p110delta/p85alpha (Homo sapiens (Human)) | BDBM261164 (1-(4-(3-(1-(4-amino-3-methyl-1H- pyrazolo[3,4-d]py...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | 6.7 | 25 |
Incyte Holdings Corporation; Incyte Corporation US Patent | Assay Description Lipid kinase substrate, phosphoinositol-4,5-bisphosphate (PIP2), are purchased from Echelon Biosciences (Salt Lake City, Utah). PI3K isoforms α,... | US Patent US9707233 (2017) BindingDB Entry DOI: 10.7270/Q2S46V0R | |||||||||||
More data for this Ligand-Target Pair |